Mark Sheptoff Financial Planning’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Mark Sheptoff Financial Planning’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,500	Closed	-$78K	–	570
2025 Q4	$78K	Buy	+2,500	New	+$61.6K	0.04%	169
2025 Q1	–	Sell	-3,000	Closed	-$66.1K	–	464
2024 Q4	$66.1K	Sell	3,000 -500	-14%	-$9.1K	0.04%	155
2024 Q3	$63.1K	Hold	3,500	–	–	0.03%	156
2024 Q2	$56.9K	Buy	+3,500	New	+$53.9K	0.03%	171
2015 Q3	–	Sell	-42	Closed	-$2K	–	442
2015 Q2	$2K	Buy	+42	New	+$2.59K	﹤0.01%	331

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Mark Sheptoff Financial Planning's TEVA Position: Q1 2026 in Review

Mark Sheptoff Financial Planning sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2026, closing a stake of 2,500 shares — an estimated $78K sold.

Mark Sheptoff Financial Planning first reported a position in TEVA in Q2 2015 and held it in 5 quarters. The position peaked at $78K in Q4 2025. 653 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

Mark Sheptoff Financial Planning reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2026 after selling out during the quarter.
Mark Sheptoff Financial Planning sold 2,500 Teva Pharmaceutical Industries Limited shares in Q1 2026, an estimated $78K.
Mark Sheptoff Financial Planning first reported a position in Teva Pharmaceutical Industries Limited in Q2 2015 and held it in 5 quarters.
Mark Sheptoff Financial Planning's Teva Pharmaceutical Industries Limited position peaked at $78K in Q4 2025.
653 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2026.

Based on Mark Sheptoff Financial Planning's 13F filing for Q1 2026, filed 11 May 2026.